Paula Gergen
Lawyers
Filters
Oruka Therapeutics $700 million follow-on offering
We advised Oruka on the offering
Revolution Medicines $2.2 billion common stock and convertible notes offerings
We advised the underwriters on the concurrent offerings
Robinhood Ventures Fund I IPO and NYSE listing
We advised Robinhood on the establishment of Robinhood Ventures and the IPO and NYSE listing of Robinhood Ventures Fund I
Ultra Clean Holdings $600 million convertible notes offering
We advised Ultra Clean on the offering
Olema Pharmaceuticals $218.5 million follow-on offering
We advised the underwriters on the offering
Oruka Therapeutics $200 million at-the-market offering
We advised Oruka on the offering
Oruka Therapeutics $180 million private placement
The PIPE included common stock and pre-funded warrants
Maze Therapeutics $150 million private placement
The PIPE included common stock and pre-funded warrants
MARA Holdings $950 million convertible notes offering
The 0% convertible senior notes are due 2032
xAI $3 billion senior secured notes offering
The senior secured notes are due 2030